Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi

Infection and Immunity

Volumn 71, Issue 6, 2003, Pages 3437-3442

  Burchill, Matthew A ^a,b   Nardelli, Dean T ^a,b   England, Douglas M ^c,d   DeCoster, David J ^a,b   Christopherson, John A ^a,b   Callister, Steven M ^e   Schell, Ronald F ^a,b  

^a WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d MERITER HOSPITAL   (United States)

^e GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 17 RECEPTOR ANTIBODY; RECOMBINANT CYTOKINE; RECOMBINANT INTERLEUKIN 17; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BORRELIA BURGDORFERI; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; OSTEOARTHROPATHY; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION;

ANIMALS; ANTIBODIES; BACTERIAL VACCINES; BORRELIA BURGDORFERI; INTERFERON TYPE II; INTERLEUKIN-17; LYME DISEASE; MICE; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-17; RECOMBINANT PROTEINS; VACCINATION;

EID: 0038781741     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.6.3437-3442.2003     Document Type: Article

References (36)

1. Aggarwal, S., and A. L. Gurney. 2001. IL-17: prototype member of an emerging cytokine family. J. Leukoc. Biol. 71:1-8.
2. Albanesi, C., C. Scarpo, N. I. A. Carvani, M. Federici, F. Nasorri, and G. Girolomoni. 2000. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma and interleukin-4-induced activation of human keratinocytes. J. Investig. Dermatol. 115:81-87.
3. Anguita, J., S. W. Barthold, R. Persinski, M. N. Hedrick, C. A. Huy, R. J. Davis, R. A. Flavell, and E. Fikrig. 2002. Murine Lyme arthritis development mediated by p38 mitogen-activated protein kinase activity. J. Immunol. 168:6352-6357.
4. Barthold, S. W., K. D. Moody, G. A. Terwilliger, P. H. Duray, R. O. Jacoby, and A. C. Steere. 1988. Experimental Lyme arthritis in rats infected with Borrelia burgdorferi. J. Infect. Dis. 157:842-846.
5. Barthold, S. W., D. S. Beck, G. M. Hansen, G. A. Terwilliger, and K. D. Moody. 1990. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162:133-138.
6. Brown, C. R., and S. L. Reiner. 1999. Experimental Lyme arthritis in the absence of interleukin-4 or gamma interferon. Infect. Immun. 67:3329-3333.
7. Bush, K. A., J. S. Walker, C. S. Lee, and B. W. Kirkham. 2001. Cytokine expression and synovial pathology in the initiation and spontaneous resolution phases of adjuvant arthritis: interleukin-17 expression is upregulated in early disease. Clin. Exp. Immunol. 123:487-495.
8. Cai, L., J. Yin, M. A. Starovasnik, D. A. Hogue, K. J. Hillan, J. S. Mort, and E. H. Filvaroff. 2001. Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo. Cytokine 16:10-21.
9. Chabaud, M., P. Garnero, J. M. Dayer, P. A. Guerne, F. Fossiez, and P. Miossec. 2000. Contribution of interleukin-17 to synovium matrix destruction in rheumatoid arthritis. Cytokine 12:1092-1099.
10. Chabaud, M., J. M. Durand, N. Bush, F. Fossiez, G. Page, L. Frapport, and P. Miossec. 1999. Human interleukin-17: a T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum. 42:963-970.
11. Chabaud, M., F. Fossiez., J. L. Taupin, and P. Miossec. 1998. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation of Th2 cytokines. J. Immunol. 161:409-414.
12. Christopherson, J. A., E. L. Munson, D. M. England, C. L. Croke, M. C. Remington, M. L. Molitor, D. J. DeCoster, S. M. Callister, and R. F. Schell. 2003. Destructive arthritis in vaccinated interferon gamma-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor alpha. Clin. Diagn. Lab. Immunol. 10:44-52.
13. Creson, J. R., L. C. L. Lim, N. J. Glowacki, S. M. Callister, and R. F. Schell. 1996. Detection of anti-Borrelia burgdorferi antibody responses with the borreliacidal antibody test, indirect fluorescent-antibody assay performed by flow cytometry, and Western immunoblotting. Clin. Diagn. Lab. Immunol. 3:184-190.
14. Croke, C. L., E. L. Munson, S. D. Lovrich, J. A. Christopherson, M. C. Remington, D. M. England, S. M. Callister, and R. F. Schell. 2000. Occurrence of severe destructive Lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi. Infect. Immun. 68:658-663.
15. Deon, D., S. Ahmed, D. Tai, N. Scaletta, C. Herrero, I. Lee, A. Krause, and L. B. Ivashkiv. 2001. Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts. J. Immunol. 167:5395-5403.
16. Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, D. Blanchard, C. Gaillard, B. Das Mahapatra, E. Rouveir, P. Golstein, J. Banchereau, and S. Lebecque. 1996. T-cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183:2593-2603.
17. Infante-Duarte, C., H. F. Horton, M. C. Byrne, and T. Kamradt. 2000. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165:6107-6115.
18. Ivashkiv, L. B. 1996. Cytokine expression and cell activation in inflammatory arthritis. Adv. Immunol. 63:337-376.
19. Jovanovic, D. V., J. A. Di Battista, J. Martel-Pelletier, F. C. Jolicoeur, Y. He., M. Zhang, F. Mineau, and J. P. Pelletier. 1998. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1β and TNF-α by human macrophages. J. Immunol. 160:3513-3521.
20. Katake, S., N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M. T. Gillespie, T. J. Martin, and T. Suda. 1999. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J. Clin. Investig. 103:1345-1352.
21. Katz, Y., O. Nadiv, and Y. Beer. 2001. Interleukin-17 enhances tumor necrosis factor α-induced synthesis of interleukin 1, 6 and 8 in skin and synovial fibroblasts. Arthritis Rheum. 44:2176-2184.
22. Keane-Myers, A., and S. P. Nickell. 1995. Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 155:2020-2028.
23. Lim, L. C. L., D. M. England, B. K. DuChateau, N. J. Glowacki, and R. F. Schell. 1995. Borrelia burgdorferi-specific T lymphocytes induce severe destructive Lyme arthritis. Infect. Immun. 63:1400-1408.
24. + T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters. Infect. Immun. 63:4818-4825.
25. Lim, L. C. L., D. M. England, B. K. DuChateau, N. J. Glowacki, J. R. Creson, S. D. Lovrich, S. M. Callister, D. A. Jobe, and R. F. Schell. 1994. Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi. Infect. Immun. 62:2825-2833.
26. Lubberts, E., L. A. B. Joosten, B. Oppers, L Van den Bersselaar, C. J. J. Coenen-de-Roo, J. D. Kolles, P. Schwarzenberger, F. A. J. Van de Loo, and W. B. Van den Berg. 2001. IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis. J. Immunol. 167:1004-1013.
27. Piquet, P. F., G. E. Grau, G. Vesin, H. Loetscher, R. Gentz, and W. Leslauer. 1992. Evolution of collagen arthritis in mice is arrested by treatment with anti-tumor necrosis factor (TNF) antibody or a recombinant soluble TNF receptor. Immunology 77:510-514.
28. Rose, C. D., P. T. Fawcett, and K. M. Gibney. 2001. Arthritis following recombinant osp A vaccination for Lyme disease. J. Rheumatol. 28:1400-1408.
29. Saez-Llorens, X., H. S. Jafari, D. D. Olsen, H. Naruichi, E. J. Hansen, and G. H. McCraken, Jr. 1991. Induction of suppurative arthritis in rabbits by Haemophilus endotoxin, tumor necrosis factor-α and interleukin-1β. J. Infect. Dis. 163:1267-1272.
30. Schmitz, J. L., R. F. Schell, A. Hejka, D. M. England, and L. Konick. 1988. Induction of Lyme arthritis in LSH hamsters. Infect. Immun. 56:2336-2342.
31. Shalom-Barak, T., J. Quach, and M. Lotz. 1998. Interleukin-17 induced gene expression in articular chondrocytes is associated with activation of mitogenactivated protein kinases and NF-κB. J. Biol. Chem. 273:27467-27473.
32. Shingu, M., T. Isayama, C. Yasutake, T. Naono, M. Nobunaga, K. Tomari, K. Horie, and Y. Goto. 1994. Role of oxygen radicals and IL-6 in IL-1-dependent cartilage matrix degradation. Inflammation 18:613-623.
33. Steel, R. G. D., and J. H. Torrie. 1960. Principles and procedures of statistics with special references to the biological sciences, p. 90-160. McGraw-Hill Book Co., New York, N.Y.
34. Steere, A. C., R. T. Schoen, and E. Taylor. 1987. The clinical evolution of Lyme arthritis. Ann. Intern. Med. 107:725-731.
35. Yang, L., J. Weiss, E. Eichwald, C. Kolbert, D. Persing, and J. Weiss. 1994. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect. Immun. 62:492-500.
36. Ziolkowska, M., A. Koc, G. Luszczykiewicz, K. Ksiezopolska-Pietrzak, E. Klimczak, H. Chwalinska-Sadowska, and W. Maslinski. 2000. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164:2832-2838.